Published by Benjamin Chiou on 30th April 2025
(Sharecast News) - Swiss pharma giant Novartis announced on Wednesday that it is to buy American clinical-stage biopharma firm Regulus for up to $1.7bn, bolstering its position in the renal disease treatment market.
URL: http://www.digitallook.com/dl/news/story/35048130/...